Nachrichten zur Johnson & Johnson Aktie

Beat the Dow Jones With This Unstoppable Dividend Stock

Johnson & Johnson has outperformed the Dow so far this year....…

Johnson & Johnson stock rises Friday, still underperforms market

Johnson & Johnson stock rises Friday, still underperforms market...…

J&J Makes a $16.6 Billion Bet on Heart Pumps to Lift Medical-Device Sales

J&J wanted a deal to boost its medical-device division, which will become more important after the company sheds its consumer-health…

Is Johnson & Johnson an Underrated Growth Stock?

Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium....…

Hot Stocks: VRNS, ZBRA plunge on earnings; IDXX climbs; ABMD surges 50% on JNJ merger deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Weiss Law Investigates Abiomed, Inc.

NEW YORK, Nov. 1, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of…

Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup

Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup...…

Johnson & Johnson: Multi-Milliarden-Deal sorgt für Aufsehen - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Benjamin Heimlich vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

J&J Agrees to Buy Heart-Device Maker Abiomed for $16.6 Billion

The deal would add heart pumps, a fast-growing part of the medical-device industry, to the J&J lineup....…

J&J kauft Medizintechnik ein

Um den gesamten Artikel unter boersen-zeitung.de zu lesen, klicken Sie bitte auf die Überschrift...…

Abiomed unlikely to see higher bid given size of J&J premium - analyst

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pre-Markets Up Ahead of New Fed Hike, Q3 Beats

Big Pharma giants Pfizer (PFE) and Lilly (LLY) posted beats on both top and bottom lines this morning, while J&J…

Johnson & Johnson: Kurssprung nach Übernahme-Ankündigung

Nachdem bislang eher mauen M&A-Jahr im Medtech-Sektor sorgt Johnson & Johnson am Dienstag mit einem Multi-Milliarden-Deal für Aufsehen. Der Konzern…

Shareholder Alert: Ademi LLP investigates whether ABIOMED, Inc. has obtained a Fair Price in its transaction with Johnson & Johnson

MILWAUKEE, Nov. 1, 2022 /PRNewswire/ -- Ademi LLP is investigating ABIOMED (NASDAQ: ABMD) for possible breaches of fiduciary duty and…

Johnson & Johnson said to have approached Abiomed

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J to buy heart medical tech firm Abiomed for $17.3bn

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Medizintechnik: Johnson & Johnson will Herzpumpenhersteller für 16,6 Milliarden Dollar kaufen

Technologie zur Behandlung von Herzerkrankungen ist ein Wachstumsmarkt. Mit einem Milliardendeal will Johnson & Johnson von dem Boom profitieren....…

J&J to Buy Heart Medical Tech Firm Abiomed for $17.3 Billion

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Medizintechnik: Milliardendeal: Johnson & Johnson will Herzpumpenhersteller kaufen

Technologie zur Behandlung von Herzerkrankungen ist ein Wachstumsmarkt - mit einem Milliardendeal will Johnson & Johnson von dem Boom profitieren....…

Abiomed Stock Soars After $16.6 Billion Johnson & Johnson Takeover Amid Deeper Medical Devices Push

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Abiomed Stock Surges on Johnson & Johnson Takeover

The pharmaceutical giant will buy the heart-pump maker for $380 a share....…

WDH: Johnson & Johnson will Herzpumpenhersteller Abiomed kaufen

(Im ersten Satz wurde ein überflüssiger Wortteil gestrichen.)NEW BRUNSWICK (dpa-AFX) - Der Gesundheitskonzern Johnson & Johnson (JohnsonJohnson) will mit einem…

Abiomed To Be Bought By Johnson & Johnson In $16.6 Bln Deal; Stock Surges In Pre-market

NEW BRUNSWICK (dpa-AFX) - Drug major Johnson & Johnson (JNJ) Tuesday said it has entered into a definitive agreement to…

Johnson & Johnson will Herzpumpenhersteller Abiomed kaufen

NEW BRUNSWICK (dpa-AFX) - Der Gesundheitskonzern Johnson & Johnson (JohnsonJohnson) will mit einem Milliardenzukauf sein Geschäft mit Medizintechnikgeschäft stärken. Das…

J&J to buy cardio technology company Abiomed for $16.6B

Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device…

J&J to buy cardiovascular technology Abiomed in $16.6B deal

Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device…

Johnson & Johnson expands MedTech footprint with acquisition of Abiomed

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson to buy medtech company Abiomed for $380 per share in cash

Johnson & Johnson is set to buy medical device company Abiomed in cash for $380 per share. CNBC's 'Squawk Box'…

Abiomed stock rockets after J&J buyout deal valued at $16.6 billion

Shares of Abiomed Inc. rocketed 48.8% toward a 14-month high in premarket trading Tuesday, after the provider of medical…

J&J to buy Abiomed in $16.6 billion deal

...(Reuters) - Johnson & Johnson said on Tuesday it will acquire......…

UPDATE 1-J&J to buy Abiomed in $16.6 bln deal

...(Adds deal details) Nov 1 (Reuters) - Johnson & Johnson said......…

Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal

Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal...…

Johnson & Johnson to Acquire Abiomed

NEW BRUNSWICK, N.J. & DANVERS, Mass.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ), the worlds largest, most diversified healthcare products company, and…

J&J to buy Abiomed in $16.6 bln deal

...Nov 1 (Reuters) - Jonhson & Johnson said on Tuesday it will acquire......…

Johnson & Johnson stock outperforms market despite losses on the day

Johnson & Johnson stock outperforms market despite losses on the day...…

J&J suspends enrollment in clinical trial assessing Essa Pharmas prostate cancer treatment

Shares of Essa Pharma Inc. fell 28.6% in premarket trading on Monday after the company said Johnson & Johnson…

Sonnet stock soars 16% on collaboration with J&J for 3 drug compounds

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ESSA drops 26% as Johnson & Johnson ends trial enrollment for lead asset

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bundesrat Guy Parmelin eröffnet den modernsten Innovationspark der Schweiz

Rund 70 Prozent der Fläche sind an 38 Firmen und Institutionen vermietet, darunter zahlreiche Startups, aber auch grosse Unternehmen wie…

Johnson & Johnson stock rises Friday, still underperforms market

Johnson & Johnson stock rises Friday, still underperforms market...…

The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Walmart, The Coca-Cola Company and NVIDIA

UnitedHealth Group, Johnson & Johnson, Walmart, The Coca-Cola Company and NVIDIA are part of the Zacks top Analyst Blog....…

Top Analyst Reports for UnitedHealth, Johnson & Johnson, & Walmart

Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ)…

Insiderhandel: Exec VP, Chief HR Officer verkauft Aktien von Johnson & Johnson im Wert von 13.435.616$

Fasolo, Peter - Vorstand - Tag der Transaktion: 2022-10-24...…

Insiderhandel: Vorstand verkauft Aktien von Johnson & Johnson im Wert von 2.573.220$

Hait, William - Vorstand - Tag der Transaktion: 2022-10-24...…

Johnson & Johnson stock outperforms market on strong trading day

Johnson & Johnson stock outperforms market on strong trading day...…

Johnson & Johnson stock underperforms Tuesday when compared to competitors

Johnson & Johnson stock underperforms Tuesday when compared to competitors...…

U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

TECVAYLI™, an off-the-shelf, subcutaneous therapy, is an important new medicine for patients with incurable blood cancer who face limited treatment…

dpa-AFX ProFeed